Lilly Announces a Call for Articles Into 2007 Luminous Award
01 June 2007 - 11:00PM
PR Newswire (US)
Luminous Award recognizes outstanding cancer journalism from
outlets around the world INDIANAPOLIS, June 1
/PRNewswire-FirstCall/ -- Following the success of the inaugural
Luminous Award in 2006, Lilly Oncology announced today the call for
entries to Luminous 2007. The Luminous Award was created by Lilly
to honour journalism that serves readers and viewers by providing
responsible, accurate and timely information on advances in cancer
prevention, research, development and treatment. Open to all
journalists reporting for newspapers, consumer magazines,
newsletters, websites and broadcast outlets, entries are judged on
a series of criteria including news value, the ability to stimulate
awareness about advances in oncology, effective communication for
the intended audience and creativity. The closing deadline for
entries is 1 September 2007, and the winner will be announced
during the European Conference on Clinical Oncology (ECCO), 23 - 27
September 2007. The winner of the Luminous Award will have the
opportunity to choose a seven-day trip for two people to Boston,
London, New York, Paris or Sydney, to be enlightened by the work of
a world-renowned oncologist or cancer researcher. As an alternative
to the trip, the winner may choose a cash donation of euro 10,000
made in the form of a scholarship, in their name, to help a student
continue his or her studies to become a journalist and enlighten
others through his or her work. There will also be a runner-up
prize of five days for two to either London or New York where he or
she will have the opportunity to meet with a world- renowned
oncologist or cancer researcher who will share their insights.
Alternatively, the runner-up may select a cash donation of euro
5,000 made in the form of a scholarship, in their name, to help a
student continue his or her studies to become a journalist and
enlighten others through his or her work. Certain local
restrictions may apply regarding this Journalism Award and it is
only available where not prohibited or restricted by local laws and
regulations. For further information and an entry form, please
contact: Gina Worthington Christine Van Marter Luminous Award
Secretariat Eli Lilly and Company Tel: +44 207 395 7180 Tel: +1 317
651-1473 Fax: +44 207 395 7101 Email: E-mail: About Lilly Oncology,
a Division of Eli Lilly and Company For more than four decades,
Lilly Oncology has been collaborating with cancer researchers to
deliver innovative treatment choices and valuable programs to
patients and physicians worldwide. Inspired by the courageous
patients living with cancer, Lilly Oncology is providing treatments
that are considered global standards of care and developing a broad
portfolio of novel targeted therapies to accelerate the pace and
progress of cancer care. About Eli Lilly and Company Lilly, a
leading innovation-driven corporation, is developing a growing
portfolio of first-in-class and best-in-class pharmaceutical
products by applying the latest research from its own worldwide
laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Ind., Lilly provides
answers -- through medicines and information -- for some of the
world's most urgent medical needs. O-LLY (Logo:
http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO
http://www.newscom.com/cgi-bin/prnh/20070601/CLF003LOGO )
http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO
http://www.newscom.com/cgi-bin/prnh/20070601/CLF003LOGO DATASOURCE:
Eli Lilly and Company CONTACT: Christine Van Marter, of Eli Lilly
and Company, +1-317-651-1473,
Copyright